IMS Health Holdings, Inc. (NYSE:IMS) shares fell -0.31% in last trading session and ended the day at $25.33. IMS Gross Margin is 53.40% and its has a return on assets of 5.60%. IMS Health Holdings, Inc. (NYSE:IMS) quarterly performance is -8.72%.
IMS Health (NYSE:IMS) announced that VAYA Pharma, a specialty medical food division of Enzymotec Ltd. (NASDAQ:ENZY), has adopted IMS Health’s Nexxus™ Mobile Intelligence CRM solution to support the successful expansion of VAYA’s sales team and commercial operations. Designed for the life sciences market, this mobile field solution seamlessly integrates IMS Health, industry data and VAYA intelligence with decision-support tools to fuel more coordinated and productive customer engagements.
Olympic Steel Inc. (NASDAQ:ZEUS) ended the last trading day at $10.92. Company weekly volatility is calculated as 7.37% and price to cash ratio as 24.02. Olympic Steel Inc. (NASDAQ:ZEUS) showed a weekly performance of 13.87%.
Olympic Steel, Inc. (NASDAQ: ZEUS), a leading national metals service center, announced the Company’s Board of Directors approved a regular quarterly cash dividend of $0.02 per share. The dividend is payable on March 15, 2016, to shareholders of record on March 1, 2016.
On 18 February, Argo Group International Holdings, Ltd. (NASDAQ:AGII) shares moved up 1.78% and was closed at $54.27. AGII EPS growth in last 5 year was 14.80%. Argo Group International Holdings, Ltd. (NASDAQ:AGII) year to date (YTD) performance is -9.31%.
Argo Group International Holdings, Ltd. (NASDAQ: AGII), an international underwriter of specialty insurance and reinsurance products, announced its board of directors has declared a quarterly cash dividend of $0.22 per share on the company’s common stock, compared to $0.20 per share the previous quarter. The dividend will be paid on March 15, 2016, to shareholders of record on March 1, 2016.
Arrowhead Research Corp. (NASDAQ:ARWR) shares fell -4.06% in last trading session and ended the day at $3.78. ARWR has a return on assets of -80.70%. Arrowhead Research Corp. (NASDAQ:ARWR) quarterly performance is -34.03%.
On 9 February, Arrowhead Research Corp. (NASDAQ:ARWR) reported a loss of $19.3 million in its fiscal first quarter. The Pasadena, California-based company said it had a loss of 32 cents per share. The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 38 cents per share. The drug developer posted revenue of $44,000 in the period.
Cambrex Corporation. (NYSE:CBM) caters to the Healthcare space. It has a net profit margin of 13.20% and weekly performance is 4.24%. On the last day of trading company shares ended up at $37.89. Cambrex Corporation. (NYSE:CBM) distance from 50-day simple moving average (SMA50) is -11.14%.
On 9 February, Cambrex Corporation. (NYSE:CBM) reported Sales were $156.9 million, compared to $128.8 million in the same period last year, representing a 22% increase. Foreign exchange unfavorably impacted reported sales growth by 3%. The sales increase primarily reflects higher volumes of certain branded active pharmaceutical ingredients (APIs) sold to innovator customers and higher volumes of generics.